You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
|
|---|---|
| Published in |
Clinics, October 2021
|
| DOI | 10.6061/clinics/2021/e3286 |
| Pubmed ID | |
| Authors |
Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza |
| Abstract |
SARS-CoV-2 vaccinations are not free from side effects. Usually, they are mild or moderate but occasionally severe. One of these severe side effects is Guillain-Barré syndrome (GBS). This review summarizes and discusses GBS as a side effect of SARS-CoV-2 vaccinations (SCoVaG) based on recent research reports. Altogether, nine articles reporting 18 patients with SCoVaG were identified and one more report on another patient is under review. The age for the studies ranged between 20-86y. Nine patients were male, and ten were female. In all 19 patients, SCoVaG developed after the first dose of the vaccine. The Astra Zeneca vaccine was used in fourteen patients, the Pfizer vaccine in four patients, and the Johnson & Johnson vaccine was applied in one patient. The latency between vaccination and onset of GBS ranged from 3h to 39d. The treatment of SCoVaG included IVIGs (n=13), steroids (n=3), or no therapy (n=3). Six patients required mechanical ventilation. Only a single patient recovered completely and partial recovery was achieved in nine patients. In conclusion, GBS may develop time-linked to the first dose of a SARS-CoV-2 vaccination. Though a causal relationship between SARS-CoV-2 vaccinations and SCoVaG remains speculative, more evidence is in favour than against it. |
X Demographics
The data shown below were collected from the profiles of 226 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 33 | 15% |
| United States | 8 | 4% |
| Canada | 3 | 1% |
| United Kingdom | 2 | <1% |
| France | 2 | <1% |
| Austria | 2 | <1% |
| Honduras | 1 | <1% |
| China | 1 | <1% |
| Spain | 1 | <1% |
| Other | 4 | 2% |
| Unknown | 169 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 219 | 97% |
| Practitioners (doctors, other healthcare professionals) | 5 | 2% |
| Scientists | 2 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 112 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 14% |
| Student > Master | 9 | 8% |
| Other | 6 | 5% |
| Researcher | 5 | 4% |
| Student > Postgraduate | 5 | 4% |
| Other | 18 | 16% |
| Unknown | 53 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 21% |
| Neuroscience | 7 | 6% |
| Nursing and Health Professions | 5 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Other | 12 | 11% |
| Unknown | 57 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 143. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2024.
All research outputs
#299,148
of 25,976,786 outputs
Outputs from Clinics
#12
of 1,232 outputs
Outputs of similar age
#7,663
of 442,138 outputs
Outputs of similar age from Clinics
#1
of 19 outputs
Altmetric has tracked 25,976,786 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,232 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.